0001209191-21-051214.txt : 20210812
0001209191-21-051214.hdr.sgml : 20210812
20210812173722
ACCESSION NUMBER: 0001209191-21-051214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210810
FILED AS OF DATE: 20210812
DATE AS OF CHANGE: 20210812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Detke Michael J.
CENTRAL INDEX KEY: 0001770786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 211168961
MAIL ADDRESS:
STREET 1: C/O CORTEXYME, INC.
STREET 2: 269 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cortexyme, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 269 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 269 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-10
0
0001662774
Cortexyme, Inc.
CRTX
0001770786
Detke Michael J.
C/O CORTEXYME, INC.
269 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2021-08-10
4
M
0
10000
2.23
A
10000
D
Common Stock
2021-08-10
4
S
0
10000
100.00
D
0
D
Stock Option (right to buy)
2.23
2021-08-10
4
M
0
10000
0.00
D
2028-11-27
Common Stock
10000
92352
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2021.
The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.
/s/ Caryn Gordon McDowell, Attorney-in-Fact for Michael J. Detke, M.D.
2021-08-12